Petersen L J, Mosbech H, Skov P S
Department of Dermatology, Bispebjerg Hospital, Copenhagen NV, Denmark.
J Allergy Clin Immunol. 1996 Feb;97(2):672-9. doi: 10.1016/s0091-6749(96)70313-5.
The purposes of the study were to characterize allergen-induced histamine release in intact human skin in vivo by using a novel microdialysis technique and to study covariates influencing histamine releasability.
Hollow microdialysis fibers were inserted into the upper dermis in 15 timothy-sensitivity subjects. Up to 12 fibers were inserted in each subject. Each fiber was perfused with Krebs-Ringer's solution at a rate of 3.0 microliters/min. Three to four serial dilutions of allergen were applied to the skin by intracutaneous injections or skin prick test above individual fibers. Samples were collected in two 2-minute fractions before skin challenge and in 10 consecutive samples for 20 minutes after skin challenge. Histamine was assayed spectrofluorometrically.
A significant dose-response relationship for histamine release was demonstrated with intracutaneous tests and skin prick tests. The time to reach peak histamine release after an intracutaneous test was 4 to 8 minutes, compared with 12 to 14 minutes for a skin prick test. Histamine release correlated significantly with wheal size. Intrasubject coefficient of variation on histamine release was about 20%. A substantial intersubject variation in histamine releasability was observed. Seventy to seventy-five percent of the variation could be accounted for by a combination of gender, total and allergen-specific IgE, and an in vitro basophil histamine release test.
Using a skin microdialysis technique, we have described in detail histamine release in intact human skin by allergen. The microdialysis method proved to be a reproducible technique for monitoring histamine release in allergic skin reactions and for studying histamine releasability of skin mast cells in vivo.
本研究的目的是通过一种新型微透析技术来描述变应原诱导的体内完整人类皮肤中的组胺释放,并研究影响组胺释放能力的协变量。
将中空微透析纤维插入15名对梯牧草敏感的受试者的真皮上层。每名受试者最多插入12根纤维。每根纤维以3.0微升/分钟的速率用 Krebs-Ringer 溶液灌注。通过皮内注射或在各纤维上方进行皮肤点刺试验,将变应原的三到四个系列稀释液应用于皮肤。在皮肤激发前,以两个2分钟的时间段收集样本,在皮肤激发后连续收集10个样本,持续20分钟。采用荧光分光光度法测定组胺。
皮内试验和皮肤点刺试验均显示组胺释放存在显著的剂量反应关系。皮内试验后达到组胺释放峰值的时间为4至8分钟,而皮肤点刺试验为12至14分钟。组胺释放与风团大小显著相关。组胺释放的受试者内变异系数约为20%。观察到受试者之间组胺释放能力存在很大差异。70%至75%的变异可由性别、总 IgE 和变应原特异性 IgE 以及体外嗜碱性粒细胞组胺释放试验共同解释。
使用皮肤微透析技术,我们详细描述了变应原在完整人类皮肤中的组胺释放情况。微透析方法被证明是一种可重复的技术,用于监测过敏性皮肤反应中的组胺释放以及研究体内皮肤肥大细胞的组胺释放能力。